← All tickers

Is PGEN Worth Buying in 2026?

Precigen, Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-23

Here’s whether Precigen, Inc. Common Stock (PGEN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+11.22% over 10 days); RSI 58 — healthy momentum range; strong 1-year return of +97.8%; 3-month momentum positive (+69.8%). Currently 4.0% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

PGEN is in a confirmed uptrend, trading above both its 50-day ($5.78) and 200-day ($4.50) moving averages. An RSI of 58.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +97.8% compares to +20.5% for SPY (beat the market by 77.3%).

$10,000 invested 1 year ago → $19,780 today
vs. S&P 500 (SPY) — same period beat market by 77.3%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($4.50)
✓Above 50-day MA ($5.78)
✓RSI(14) neutral zone (30–70) — currently 58.5
✓Positive return (+97.8%)
✓Within 10% of period high (−4.0%)
Period Range $7.20
$2.99 $7.50
RSI (14) 58.5
0 · OversoldOverbought · 100

Key Metrics

Price$7.20
Period Return+97.8%
Period High$7.50
Period Low$2.99
Drawdown−4.0%
MA-50$5.78
MA-200$4.50
RSI (14)58.5
Avg Volume (30d)5.3M
vs. SPYbeat by 77.3%
Return Rank#131 of 999

Trade PGEN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers